Page 2202 - Williams Hematology ( PDFDrive )

2176 Part XII: Hemostasis and Thrombosis Chapter 126: von Willebrand Disease 2177

18. Bonthron DT, Handin RI, Kaufman RJ, et al: Structure of pre-pro-von Willebrand 51. Voorberg J, Fontijn R, Calafat J, et al: Assembly and routing of von Willebrand fac-
factor and its expression in heterologous cells. Nature 324:270–273, 1986. tor variants: The requirements for disulfide-linked dimerization reside within the
19. Bonthron DT, Orr EC, Mitsock LM, et al: Nucleotide sequence of pre-pro-von carboxy-terminal 151 amino acids. J Cell Biol 113:195–205, 1991.
Willebrand factor cDNA. Nucleic Acids Res 14:7125–7127, 1986. 52. Mayadas TN, Wagner DD: Vicinal cysteines in the prosequence play a role in von
20. Shelton-Inloes BB, Broze GJ Jr, Miletich JP, Sadler JE: Evolution of human von Willebrand factor multimer assembly. Proc Natl Acad Sci U S A 89:3531–3535, 1992.
Willebrand Factor: CDNA sequence polymorphisms, repeated domains, and relation- 53. Purvis AR, Sadler JE: A covalent oxidoreductase intermediate in propeptide-dependent
ship to von Willebrand antigen II. Biochem Biophys Res Commun 144:657–665, 1987. von Willebrand factor multimerization. J Biol Chem 279:49982–49988, 2004.
21. Shelton-Inloes BB, Titani K, Sadler JE: CDNA sequences for human von Willebrand 54. Mayadas TN, Wagner DD: In vitro multimerization of von Willebrand factor is trig-
Factor reveal five types of repeated domains and five possible protein sequence poly- gered by low pH: Importance of the propolypeptide and free sulfhydryls. J Biol Chem
morphisms. Biochemistry 25:3164–3171, 1986. 264:13497–13503, 1989.
22. Springer TA: Von Willebrand factor, Jedi knight of the bloodstream. Blood 124: 55. Wagner DD, Fay PJ, Sporn LA, et al: Divergent fates of von Willebrand factor and its
1412–1425, 2014. propolypeptide (von Willebrand antigen II) after secretion from endothelial cells. Proc
23. Colombatti A, Bonaldo P: The superfamily of proteins with von Willebrand factor type Natl Acad Sci U S A 84:1955–1959, 1987.
A-like domains: One theme common to components of extracellular matrix, hemostasis, 56. Verweij CL, Hart M, Pannekoek H: Expression of variant von Willebrand factor (vWF)
cellular adhesion, and defense mechanisms. Blood 77:2305–2315, 1991. cDNA in heterologous cells: Requirement of the pro-polypeptide in vWF multimer for-
24. Hunt LT, Barker WC: Von Willebrand factor shares a distinctive cysteine-rich domain with mation. EMBO J 6:2885–2890, 1987.
thrombospondin and procollagen. Biochem Biophys Res Commun 144:876–882, 1987. 57. Wise RJ, Pittman DD, Handin RI, et al: The propeptide of von Willebrand factor inde-
25. Mancuso DJ, Tuley EA, Westfield LA, et al: Structure of the gene for human von Wille- pendently mediates the assembly of von Willebrand multimers. Cell 52:229–236, 1988.
brand factor. J Biol Chem 264:19514–19527, 1989. 58. Rehemtulla A, Kaufman RJ: Preferred sequence requirements for cleavage of pro-von
26. Shelton-Inloes BB, Chehab FF, Mannucci PM, et al: Gene deletions correlate with the Willebrand propeptide-processing enzymes. Blood 79:2349–2355, 1992.
development of alloantibodies in von Willebrand disease. J Clin Invest 79:1459–1465, 59. Wagner DD, Marder VJ: Biosynthesis of von Willebrand protein by human endothe-
1987. lial cells: Processing steps and their intracellular localization. J Cell Biol 99:2123–2130,
27. Mancuso DJ, Tuley EA, Westfield LA, et al: Human von Willebrand factor gene and 1984.
pseudogene: Structural analysis and differentiation by polymerase chain reaction. 60. Lynch DC, Zimmerman TS, Ling EH, Browning PJ: An explanation for minor mul-
Biochemistry 30:253–269, 1991. timer species in endothelial cell-synthesized von Willebrand factor. J Clin Invest
28. Zhang ZP, Blomback M, Nyman D, Anvret M: Mutations of von Willebrand factor gene 77:2048–2051, 1986.
in families with von Willebrand disease in the Aland Islands. Proc Natl Acad Sci U S A 61. Verweij CL, Hart M, Pannekoek H: Proteolytic cleavage of the precursor of von Wille-
90:7937–7940, 1993. brand Factor is not essential for multimer formation. J Biol Chem 263:7921–7924, 1988.
29. Eikenboom JC, Vink T, Briet E, et al: Multiple substitutions in the von Willebrand fac- 62. Weibel ER, Palade GE: New cytoplasmic components in arterial endothelia. J Biol Chem
tor gene that mimic the pseudogene sequence. Proc Natl Acad Sci U S A 91:2221–2224, 23:101–112, 1964.
1994. 63. Wagner DD, Olmsted JB, Marder VJ: Immunolocalization of von Willebrand protein in
30. Eikenboom JC, Castaman G, Vos HL, et al: Characterization of the genetic defects in Weibel-Palade bodies of human endothelial cells. J Cell Biol 95:355–360, 1982.
recessive type 1 and type 3 von Willebrand disease patients of Italian origin. Thromb 64. Metcalf DJ, Nightingale TD, Zenner HL, et al: Formation and function of Weibel-Palade
Haemost 79:709–717, 1998. bodies. J Cell Sci 121:19–27, 2008.
31. James PD, Notley C, Hegadorn C, et al: The mutational spectrum of type 1 von Wille- 65. Huang RH, Wang Y, Roth R, et al: Assembly of Weibel-Palade body-like tubules from
brand disease: Results from a Canadian cohort study. Blood 109:145–154, 2007. N-terminal domains of von Willebrand factor. Proc Natl Acad Sci U S A 105:482–487,
32. Rand JH, Badimon L, Gordon RE, et al: Distribution of von Willebrand factor in por- 2008.
cine intima varies with blood vessel type and location. Arteriosclerosis 7:287–291, 1987. 66. Yarovoi H, Nurden AT, Montgomery RR, et al: Intracellular interaction of von Wille-
33. Yamamoto K, de Waard V, Fearns C, Loskutoff DJ: Tissue distribution and regulation of brand factor and factor VIII depends on cellular context: Lessons from platelet-
murine von Willebrand factor gene expression in vivo. Blood 92:2791–2801, 1998. expressed factor VIII. Blood 105:4674–4676, 2005.
34. Jahroudi N, Lynch DC: Endothelial-cell-specific regulation of von Willebrand factor 67. Rosenberg JB, Foster PA, Kaufman RJ, et al: Intracellular trafficking of factor VIII to
gene expression. Mol Cell Biol 14:999–1008, 1994. von Willebrand factor storage granules. J Clin Invest 101:613–624, 1998.
35. Harvey PJ, Keightley AM, Lam YM, et al: A single nucleotide polymorphism at nucle- 68. van den Biggelaar M, Bierings R, Storm G, et al: Requirements for cellular co-trafficking
otide -1793 in the von Willebrand factor (VWF) regulatory region is associated with of factor VIII and von Willebrand factor to Weibel-Palade bodies. J Thromb Haemost
plasma VWF:Ag levels. Br J Haematol 109:349–353, 2000. 5:2235–2242, 2007.
36. Guan J, Guillot PV, Aird WC: Characterization of the mouse von Willebrand factor 69. Nightingale T, Cutler D: The secretion of von Willebrand factor from endothelial cells;
promoter. Blood 94:3405–3412, 1999. an increasingly complicated story. J Thromb Haemost 11(Suppl 1):192–201, 2013.
37. Hough C, Cuthbert CD, Notley C, et al: Cell type-specific regulation of von Willebrand 70. Bonfanti R, Furie BC, Furie B, Wagner DD: PADGEM (GMP140) is a component of
factor expression by the E4BP4 transcriptional repressor. Blood 105:1531–1539, 2005. Weibel-Palade bodies of human endothelial cells. Blood 73:1109–1112, 1989.
38. Kleinschmidt AM, Nassiri M, Stitt MS, et al: Sequences in intron 51 of the von Wille- 71. Michaux G, Pullen TJ, Haberichter SL, Cutler DF: P-selectin binds to the D´-D3
brand factor gene target promoter activation to a subset of lung endothelial cells in domains of von Willebrand factor in Weibel-Palade bodies. Blood 107:3922–3924,
transgenic mice. J Biol Chem 283:2741–2750, 2008. 2006.
39. Aird WC, Jahroudi N, Weiler-Guettler H, et al: Human von Willebrand factor gene 72. Cleator JH, Zhu WQ, Vaughan DE, Hamm HE: Differential regulation of endothelial
sequences target expression to a subpopulation of endothelial cells in transgenic mice. exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and
Proc Natl Acad Sci U S A 92:4567–4571, 1995. cAMP. Blood 107:2736–2744, 2006.
40. Bernat JA, Crawford GE, Ogurtsov AY, et al: Distant conserved sequences flanking 73. Knop M, Aareskjold E, Bode G, Gerke V: Rab3D and annexin A2 play a role in regulated
endothelial-specific promoters contain tissue-specific DNase-hypersensitive sites and secretion of vWF, but not tPA, from endothelial cells. EMBO J 23:2982–2992, 2004.
over-represented motifs. Hum Mol Genet 15:2098–2105, 2006. 74. Rondaij MG, Bierings R, Kragt A, et al: Dynamics and plasticity of Weibel-Palade bod-
41. Pusztaszeri MP, Seelentag W, Bosman FT: Immunohistochemical expression of endo- ies in endothelial cells. Arterioscler Thromb Vasc Biol 26:1002–1007, 2006.
thelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. 75. Giblin JP, Hewlett LJ, Hannah MJ: Basal secretion of von Willebrand factor from
J Histochem Cytochem 54:385–395, 2006. human endothelial cells. Blood 112:957–964, 2008.
42. Hough C, Cameron CL, Notley CR, et al: Influence of a GT repeat element on shear 76. Levine JD, Harlan JM, Harker LA, et al: Thrombin-mediated release of factor VIII anti-
stress responsiveness of the VWF gene promoter. J Thromb Haemost 6:1183–1190, gen from human umbilical vein endothelial cells in culture. Blood 60:531–534, 1982.
2008. 77. Ribes JA, Francis CW, Wagner DD: Fibrin induces release of von Willebrand factor
43. Daidone V, Cattini MG, Pontara E, et al: Microsatellite (GT)(n) repeats and SNPs in from endothelial cells. J Clin Invest 79:117–123, 1987.
the von Willebrand factor gene promoter do not influence circulating von Willebrand 78. Hamilton KK, Sims PJ: Changes in cytosolic Ca associated with von Willebrand
2+
factor levels under normal conditions. Thromb Haemost 101:298–304, 2009. factor release in human endothelial cells exposed to histamine. Study of microcarrier
44. Zhou YF, Eng ET, Zhu J, et al: Sequence and structure relationships within von cell monolayers using the fluorescent probe indo-1. J Clin Invest 79:600–608, 1987.
Willebrand factor. Blood 120:449–458, 2012. 79. Hattori R, Hamilton KK, McEver RP, Sims PJ: Complement proteins C5b-9 induce
45. Ginsburg D, Bowie EJ: Molecular genetics of von Willebrand disease. Blood 79: secretion of high molecular weight multimers of endothelial von Willebrand factor and
2507–2519, 1992. translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem
46. Wagner DD: Cell biology of von Willebrand factor. Annu Rev Cell Biol 6:217–246, 1990. 264:9053–9060, 1989.
47. de Wit TR, van Mourik JA: Biosynthesis, processing and secretion of von Willebrand 80. Bernardo A, Ball C, Nolasco L, et al: Effects of inflammatory cytokines on the release
factor: Biological implications. Best Pract Res Clin Haematol 14:241–255, 2001. and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers
48. Marti T, Rosselet SJ, Titani K, Walsh KA: Identification of disulfide-bridged substruc- under flow. Blood 104:100–106, 2004.
tures within human von Willebrand factor. Biochemistry 26:8099–8109, 1987. 81. Fish RJ, Yang H, Viglino C, et al: Fluvastatin inhibits regulated secretion of endothelial
49. Choi H, Aboulfatova K, Pownall HJ, et al: Shear-induced disulfide bond formation reg- cell von Willebrand factor in response to diverse secretagogues. Biochem J 405:597–604,
ulates adhesion activity of von Willebrand factor. J Biol Chem 282:35604–35611, 2007. 2007.
50. Wagner DD, Lawrence SO, Ohlsson-Wilhelm BM, et al: Topology and order of forma- 82. Yamakuchi M, Greer JJ, Cameron SJ, et al: HMG-CoA reductase inhibitors inhibit endo-
tion of interchain disulfide bonds in von Willebrand factor. Blood 69:27–32, 1987. thelial exocytosis and decrease myocardial infarct size. Circ Res 96:1185–1192, 2005.

Kaushansky_chapter 126_p2163-2182.indd 2177 9/21/15 3:15 PM